Drug intelligence / Profile preview

Raciol

Development stage
Unknown
Lead developer
Agritec
Modality
Small Molecules, Peptides
Administration
Oral
01

Overview

Raciol is a specific variety of oilseed flax (*Linum usitatissimum* L.) of Czech origin, characterized by its high content of alpha-linolenic acid (ALA) and phenolic compounds such as lignans. It is utilized as a functional food or nutraceutical to mitigate cardiovascular risk factors, particularly in postmenopausal women. The variety's mechanism involves the systemic reduction of inflammatory markers like high-sensitivity C-reactive protein (hs-CRP) and the improvement of lipid profiles, specifically by reducing LDL cholesterol and increasing HDL cholesterol. Its bioactive components, such as secoisolariciresinol diglucoside (SDG), act as phytoestrogens and antioxidants, while its high fiber and omega-3 fatty acid content contribute to metabolic health. In clinical research, Raciol is often categorized as a low-lignan variety compared to other cultivars like Agram.

Other names
Linum usitatissimum 'Raciol'Raciol flaxseed
02

Targets

ER (Estrogen receptor)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Raciol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raciol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call